Clinical Trials on H7N9 Influenza

Total 2312 results

DiaSorin Molecular LLC

Completed

LIAISON NES Influenza (FLU) A/B & Coronavirus Disease 2019 (COVID-19) Clinical Agreement in Australia

Coronavirus Disease 2019 | Influenza A | Influenza Type B

Australia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

India
Mahidol University
Ministry of Health, Thailand; Bhumirajanagarindra Kidney Institute, Thailand

Recruiting

Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients (Enhance)

ESRD | Influenza Vaccine | Seroprotection

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

A Pilot Study for Collection of Anti-Influenza A Immune Plasma

Influenza A Virus Infection | Swine Flu

United States
University of Maryland
National Institute of Allergy and Infectious Diseases (NIAID); Centers for...

Completed

Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza (EMIT)

Influenza Virus Infection Transmission in Humans

United States
International Centre for Diarrhoeal Disease Research...
Johns Hopkins University; Centers for Disease Control and Prevention

Completed

Flu Vaccine Against Childhood Pneumonia, Bangladesh

Pneumonia | Laboratory Confirmed Influenza

Bangladesh
University of Minnesota
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Respiratory Virus Outpatient Study (FLU 002 Plus)

Influenza and Other Novel Respiratory Viruses

United States, Chile, United Kingdom, Spain, Argentina, Australia, Thailand, Peru, Germany, Japan, Greece, Belgium, Denmark, Estonia, Poland
Sanofi Pasteur, a Sanofi Company

Completed

Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults

Influenza | Swine-Origin A/H1N1 Influenza Virus

France
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Poland
South East Asia Infectious Disease Clinical Research...
University of Oxford; Wellcome Trust

Completed

Host Genetic Susceptibility to Avian Influenza A/H5N1

Influenza A Virus/H5N1 Subtype

Vietnam
St. Petersburg Research Institute of Vaccines and...

Recruiting

Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children

Vaccine Reaction | Influenza | Influenza, Human | Influenza Viral Infections

Russian Federation
Sungkyunkwan University
Government-wide R&D Fund project for infectious disease research (GFID)

Unknown

Maternal and Fetal Outcomes Following Influenza Vaccination in Pregnancy

Pregnancy Related | Influenza Virus Vaccine Adverse Reaction
The Jackson Laboratory
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Recruiting

A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults (FluVax3)

Aging | Influenza Vaccine | Vaccine Response | Dendritic Cell

United States
Advocate Health Care

Completed

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Influenza | Malignancy | Influenza Virus Vaccine Adverse Reaction (Disorder)
Janssen Research & Development, LLC

Completed

A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation

Influenza A Virus

Belgium
Janssen Vaccines & Prevention B.V.

Completed

A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Influenza, Human Prevention | Respiratory Syncytial Viruses Prevention

United States
Children's Hospital Medical Center, Cincinnati
Johns Hopkins Bloomberg School of Public Health; Bill and Melinda Gates Foundation and other collaborators

Completed

Field Trial of Maternal Influenza Immunization in Asia (Mothers'Gift)

Influenza Human

Nepal
Indiana University

Completed

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Influenza Vaccines | Human Papillomavirus Vaccines | Attitude to Health
SB Istanbul Education and Research Hospital
University of Nottingham

Completed

Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour

Influenza Vaccine | Behavioral Intervention | Self-benefit | Social-benefit

Turkey
National Institute of Allergy and Infectious Diseases...

Completed

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Influenza A Virus, H1N1 Subtype | Novel Swine-Origin

United States
Jiangsu Province Centers for Disease Control and...
Royal (Wuxi) Biological Co., LTD

Completed

Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children

Group A, C Polysaccharide Meningitis | Type b Haemophilus Influenza

China
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

HIV Infections | H1N1 Influenza Virus

United States, Puerto Rico
University of British Columbia
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR)

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

HIV Infections | H1N1 Influenza

Canada
Centers for Disease Control and Prevention, China

Completed

Immune Response Study of Influenza Vaccine

Influenza Vaccine Allergy | Cell Mediated Reaction
Centers for Disease Control and Prevention
Kenya Medical Research Institute; MCM Vaccines B.V.; Kenya Ministry of Health

Unknown

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Influenza | Severe Acute Respiratory Illness | Influenza Like Illness

Kenya
Masahiro Morikawa
White Cross Nursing Home

Completed

Effects of Tea Catechin Consumption on the Prophylaxis of Influenza Infection

Influenza Infection

Japan
University of Shizuoka
Hamamatsu University; Seirei Hamamatsu General Hospital

Completed

Catechin Containing Mask for the Prevention of Influenza Infection

Influenza Infection

Japan
Chinese University of Hong Kong
The University of Hong Kong

Recruiting

Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant Culture (COVID-19)

Coronavirus | Influenza Virus

Hong Kong
University of Shizuoka

Unknown

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

Influenza Infection

Japan
University of Shizuoka
White Cross Nursing Home; Seirei Hamamatsu General Hospital; Shizuoka General...

Completed

Catechin Gargling for Influenza Infection

Influenza Infection

Japan
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
University of Pittsburgh
Baylor College of Medicine; Centers for Disease Control and Prevention

Completed

SOP Toolkit in Diverse Practices Implemented & Tested With RE-AIM (SOP)

Adult Influenza Vaccinations | Adult PPSV Vaccinations | Adult Tdap/Td Vaccinations

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dose, Safety, Tolerability and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine in Healthy Adults

Influenza Infection

United States
Novartis Vaccines

Completed

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

Influenza Disease

Italy
National Taiwan University Hospital

Unknown

Virosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza Virus

Enterovirus 71 and Influenza Virus

Taiwan
Hospices Civils de Lyon

Terminated

Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection (Combina)

Influenza A Infection

France
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

FluSAFE: Flu SMS Alerts to Freeze Exposure

Influenza | Acute Respiratory Infection | Influenza-like Illness

United States
Novartis Vaccines

Completed

Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

Influenza Disease

Italy
University of Manitoba
Hoffmann-La Roche

Withdrawn

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

Influenza A Virus Infection | Influenza B Virus Infection

Canada
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

Influenza A Virus Infection | Influenza B Virus Infection

China
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
National Institute of Allergy and Infectious Diseases...

Completed

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

United States
Canadian Critical Care Trials Group
Canadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated... and other collaborators

Terminated

Collaborative H1N1 Adjuvant Treatment Pilot Trial (CHAT)

Critically Ill | H1N1/Influenza Infection

Canada
Novartis Vaccines

Completed

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

A New Flu Virus of Swine Origin | Pandemic Influenza A (H1N1)

Argentina, Netherlands
Joint Stock Company "Farmak"

Completed

Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

Human Influenza | Acute Respiratory Viral Infections
Asociacion Instituto Biodonostia

Completed

Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons (HOSPIGRIP)

Influenza Virus Infection

Spain
Altimmune, Inc.

Completed

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Influenza A Subtype H5N1 Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Influenza | Orthomyxoviridae Infections | Influenza A Virus Infection

Thailand
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia

Clinical Trials on H7N9 Influenza

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations